Baxter International

Baxter International is a multinational healthcare company with a focus on medical devices, pharmaceuticals, and biotechnology. It was founded in 1931 by Dr. Donald Baxter as a manufacturer and distributor of intravenous therapy solutions.

Error creating thumbnail:

Baxter flo-gard

History

Baxter International was founded in 1931 by Dr. Donald Baxter, a Los Angeles-based physician. He started the company to provide a ready source of intravenous solutions for local hospitals. In 1935, the company expanded its operations to the Midwest and East Coast through a series of acquisitions and mergers.

During the 1980s and 1990s, Baxter International diversified its product line to include biotechnology products and services. The company also expanded its global footprint, establishing operations in more than 100 countries.

Products and Services

Baxter International's product portfolio includes medical devices, pharmaceuticals, and biotechnology products. The company's medical devices segment includes products for intravenous (IV) therapy, anesthesia, dialysis, and critical care.

The pharmaceuticals segment includes injectable pharmaceuticals such as antibiotics, anesthetics, and oncology drugs. The biotechnology segment includes products for hemophilia, immune disorders, and kidney disease.

Corporate Social Responsibility

Baxter International is committed to corporate social responsibility (CSR). The company's CSR initiatives focus on improving access to healthcare, promoting sustainable operations, and fostering a diverse and inclusive workplace.

Controversies

Baxter International has faced several controversies over the years, including allegations of price-fixing, product recalls, and environmental violations. The company has taken steps to address these issues, including implementing stricter quality control measures and enhancing its corporate governance practices.

See Also

• Healthcare industry
• Medical device
• Pharmaceutical industry
• Biotechnology